Its defined molecular composition makes it suitable for experimental research protocols, in-vitro investigations, and analytical applications carried out within scientific research environments

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
Be mindful of potential side effects and discontinue use if they occur
Nascobal Dosage and Administration 2.1 Testing and Other Considerations Prior to Dosing Prior to treatment, obtain hematocrit, reticulocyte count, vitamin B12, folate, and iron levels [see Dosage and Administration (2.4)]
The vitamin B12 deficiency involved in pernicious anemia is not brought on by inadequate diet, but rather by a relatively rare condition that inhibits the absorption of vitamin B12 in the gut, per MedlinePlus Medical Encyclopedia